These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24075235)

  • 1. Management of bisphosphonate-related osteonecrosis of the jaw with a platelet-rich fibrin membrane: technical report.
    Soydan SS; Uckan S
    J Oral Maxillofac Surg; 2014 Feb; 72(2):322-6. PubMed ID: 24075235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
    Inchingolo F; Cantore S; Dipalma G; Georgakopoulos I; Almasri M; Gheno E; Motta A; Marrelli M; Farronato D; Ballini A; Marzullo A
    J Biol Regul Homeost Agents; 2017; 31(3):811-816. PubMed ID: 28958140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of bisphosphonate-related osteonecrosis of the jaw using platelet-rich fibrin.
    Gönen ZB; Yılmaz Asan C
    Cranio; 2017 Sep; 35(5):332-336. PubMed ID: 27363584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study.
    Kim JW; Kim SJ; Kim MR
    Br J Oral Maxillofac Surg; 2014 Nov; 52(9):854-9. PubMed ID: 25138613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histopathological studies using fibrin-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw.
    Dincă O; Zurac S; Stăniceanu F; Bucur MB; Bodnar DC; Vlădan C; Bucur A
    Rom J Morphol Embryol; 2014; 55(3):961-4. PubMed ID: 25329128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases.
    Mozzati M; Gallesio G; Arata V; Pol R; Scoletta M
    Oral Oncol; 2012 May; 48(5):469-74. PubMed ID: 22265335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
    Del Fabbro M; Gallesio G; Mozzati M
    Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study.
    Martins MA; Martins MD; Lascala CA; Curi MM; Migliorati CA; Tenis CA; Marques MM
    Oral Oncol; 2012 Jan; 48(1):79-84. PubMed ID: 21940198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients.
    Coviello V; Peluso F; Dehkhargani SZ; Verdugo F; Raffaelli L; Manicone PF; D' Addona A
    J Biol Regul Homeost Agents; 2012; 26(1):151-5. PubMed ID: 22475108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
    Vescovi P; Nammour S
    Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of nonsurgical therapeutic management of stage I bisphosphonate-related osteonecrosis of the jaw.
    Bodem JP; Kargus S; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2015 Sep; 43(7):1139-43. PubMed ID: 26116306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell therapy in bisphosphonate-related osteonecrosis of the jaw.
    Gonzálvez-García M; Rodríguez-Lozano FJ; Villanueva V; Segarra-Fenoll D; Rodríguez-González MA; Oñate-Sánchez R; Blanquer M; Moraleda JM
    J Craniofac Surg; 2013 May; 24(3):e226-8. PubMed ID: 23714970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model.
    Barba-Recreo P; Del Castillo Pardo de Vera JL; Georgiev-Hristov T; Ruiz Bravo-Burguillos E; Abarrategi A; Burgueño M; García-Arranz M
    J Craniomaxillofac Surg; 2015 Sep; 43(7):1161-8. PubMed ID: 26027865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the Addition of Bone Morphogenetic Protein 2 to Platelet-Rich Fibrin Improve Healing After Treatment for Medication-Related Osteonecrosis of the Jaw?
    Park JH; Kim JW; Kim SJ
    J Oral Maxillofac Surg; 2017 Jun; 75(6):1176-1184. PubMed ID: 28042979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of bisphosphonate-related osteonecrosis of the jaw (BRONJ) revealed by targeted removal of legacy bisphosphonate from jawbone using competing inert hydroxymethylene diphosphonate.
    Okawa H; Kondo T; Hokugo A; Cherian P; Campagna JJ; Lentini NA; Sung EC; Chiang S; Lin YL; Ebetino FH; John V; Sun S; McKenna CE; Nishimura I
    Elife; 2022 Aug; 11():. PubMed ID: 36017995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report.
    Giudice A; Antonelli A; Muraca D; Fortunato L
    Indian J Dent Res; 2020; 31(5):813-818. PubMed ID: 33433526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dental implications of bisphophonate-related osteonecrosis.
    Saldanha S; Shenoy VK; Eachampati P; Uppal N
    Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bisphosphonate-associated osteonecrosis of the jaw].
    Koy S; Schubert M; Koy J; Ney M; Lauer G; Sabatowski R
    Schmerz; 2015 Apr; 29(2):171-8. PubMed ID: 25860198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.